eli lilly glp-1 stock analysis has climbed 394% in five years. Novo Nordisk is essentially flat. The trade was never a basket. $LLY $NVO Josh - Eli Lilly's stock

Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure medications

So the first honest distinction is structural: tesamorelin is a modified full-length analog engineered for resistance to degradation, whereas sermorelin is an unmodified short fragment that reproduces GHRH activity but not GHRH stability

On social media, most of the microdosing chatter is about small amounts of weight loss, perceived (but not proven!) longevity benefits, and treating many forms of inflammation

In the Obesity Treatment Group, 979 patients were analyzed

However, the anti-inflammatory effects of GLP-1 agonists appear to provide benefit beyond what weight loss alone would explain

Why should I run the bac water down the side of the vial